These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 34857478)

  • 1. Elevated CD19
    Ju B; Wang J; Mo L; Huang J; Hao Z; Lv X; Pu D; He L
    Int Immunopharmacol; 2022 Jan; 102():108403. PubMed ID: 34857478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of costimulatory molecules on peripheral blood lymphocytes of patients with systemic lupus erythematosus.
    Bijl M; Horst G; Limburg PC; Kallenberg CG
    Ann Rheum Dis; 2001 May; 60(5):523-6. PubMed ID: 11302879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral CD24hi CD27+ CD19+ B cells subset as a potential biomarker in naïve systemic lupus erythematosus.
    Jin L; Weiqian C; Lihuan Y
    Int J Rheum Dis; 2013 Dec; 16(6):698-708. PubMed ID: 24286662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-21 is increased in active systemic lupus erythematosus patients and contributes to the generation of plasma B cells.
    Nakou M; Papadimitraki ED; Fanouriakis A; Bertsias GK; Choulaki C; Goulidaki N; Sidiropoulos P; Boumpas DT
    Clin Exp Rheumatol; 2013; 31(2):172-9. PubMed ID: 23137515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of immune subsets with distinct lectin binding signatures using multi-parameter flow cytometry: correlations with disease activity in systemic lupus erythematosus.
    Szabó E; Faragó A; Bodor G; Gémes N; Puskás LG; Kovács L; Szebeni GJ
    Front Immunol; 2024; 15():1380481. PubMed ID: 38774868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monocyte Siglec-14 expression is upregulated in patients with systemic lupus erythematosus and correlates with lupus disease activity.
    Thornhill SI; Mak A; Lee B; Lee HY; Poidinger M; Connolly JE; Fairhurst AM
    Rheumatology (Oxford); 2017 Jun; 56(6):1025-1030. PubMed ID: 28137763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role and clinical significance of programmed cell death- ligand 1 expressed on CD19
    Jia XY; Zhu QQ; Wang YY; Lu Y; Li ZJ; Li BQ; Tang J; Wang HT; Song CW; Xie CH; Chen LJ
    Clin Immunol; 2019 Jan; 198():89-99. PubMed ID: 30502542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered CD19/CD22 balance in Egyptian children and adolescents with systemic lupus erythematosus.
    El-Sayed ZA; Ragab SM; Khalifa KA; El Ashmawy RA
    Egypt J Immunol; 2009; 16(1):27-38. PubMed ID: 20726320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD19/22 balance relates to improvement of disease activity in systemic lupus erythematosus.
    Suzuki J; Nakano S; Nakairi Y; Mitsuo A; Amano H; Morimoto S; Tokano Y; Takasaki Y
    Mod Rheumatol; 2006; 16(4):235-8. PubMed ID: 16906374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Siglec-G deficiency leads to more severe collagen-induced arthritis and earlier onset of lupus-like symptoms in MRL/lpr mice.
    Bökers S; Urbat A; Daniel C; Amann K; Smith KG; Espéli M; Nitschke L
    J Immunol; 2014 Apr; 192(7):2994-3002. PubMed ID: 24600033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LRRK2 is involved in the pathogenesis of system lupus erythematosus through promoting pathogenic antibody production.
    Zhang M; Yao C; Cai J; Liu S; Liu XN; Chen Y; Wang S; Ji P; Pan M; Kang Z; Wang Y
    J Transl Med; 2019 Jan; 17(1):37. PubMed ID: 30670047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased T-lymphocyte apoptosis in lupus correlates with disease activity and may be responsible for reduced T-cell frequency: a cross-sectional and longitudinal study.
    Dhir V; Singh AP; Aggarwal A; Naik S; Misra R
    Lupus; 2009 Aug; 18(9):785-91. PubMed ID: 19578102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of complement activation products in Chinese patients with systemic lupus erythematosus.
    Li J; An L; Zhang Z
    Clin Exp Rheumatol; 2014; 32(1):48-53. PubMed ID: 23981509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of CD19+CD24highCD38high B cells, IL‑10 and IL‑10R in peripheral blood from patients with systemic lupus erythematosus.
    Wang T; Li Z; Li X; Chen L; Zhao H; Jiang C; Song L
    Mol Med Rep; 2017 Nov; 16(5):6326-6333. PubMed ID: 28901380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Similar CD19 dysregulation in two autoantibody-associated autoimmune diseases suggests a shared mechanism of B-cell tolerance loss.
    Culton DA; Nicholas MW; Bunch DO; Zhen QL; Kepler TB; Dooley MA; Mohan C; Nachman PH; Clarke SH
    J Clin Immunol; 2007 Jan; 27(1):53-68. PubMed ID: 17195045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients with systemic lupus erythematosus show increased proportions of CD19
    Zhu Q; Li Y; Zhang L; Wang M; Chen Z; Shi J; Li J; Li B; Li Z; Wang Y; Xie C
    Clin Rheumatol; 2021 Jan; 40(1):151-165. PubMed ID: 32542581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of BAFF, APRIL serum levels, BAFF-R, TACI and BCMA expression on peripheral B-cell subsets with clinical manifestations in systemic lupus erythematosus.
    Salazar-Camarena DC; Ortiz-Lazareno PC; Cruz A; Oregon-Romero E; Machado-Contreras JR; Muñoz-Valle JF; Orozco-López M; Marín-Rosales M; Palafox-Sánchez CA
    Lupus; 2016 May; 25(6):582-92. PubMed ID: 26424128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD19
    Xiong H; Tang Z; Xu Y; Shi Z; Guo Z; Liu X; Tan G; Ai X; Guo Q
    Adv Rheumatol; 2022 Dec; 62(1):48. PubMed ID: 36494762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of 5C11-positive activated interferon-producing cells in patients with systemic lupus erythematosus.
    Ohshima M; Kanda H; Kubo K; Yonezumi-Hayashi A; Tateishi S; Yamamoto K
    Lupus; 2013 Jan; 22(1):44-51. PubMed ID: 23087259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expansion of toll-like receptor 9-expressing B cells in active systemic lupus erythematosus: implications for the induction and maintenance of the autoimmune process.
    Papadimitraki ED; Choulaki C; Koutala E; Bertsias G; Tsatsanis C; Gergianaki I; Raptopoulou A; Kritikos HD; Mamalaki C; Sidiropoulos P; Boumpas DT
    Arthritis Rheum; 2006 Nov; 54(11):3601-11. PubMed ID: 17075805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.